Cefpirome/cytarabine/daunorubicin: Escherichia coli bacteraemia (first report for daunorubicin and cefpirome) leading to pyomyositis (first report for cefpirome): case report

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1254, 2009-01, pp. : 15-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cytarabine/daunorubicin: First report of thyroid storm: case report

By  

Reactions Weekly, Vol. 1, Iss. 1059, 2005-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Cytarabine/daunorubicin: Gastrointestinal disorders (first report of daunorubicin in ileitis and colitis): 5 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1399, 2012-01 ,pp. : 12-13

Adis International

Access to resources Recommend Favorite

Cytarabine/daunorubicin: Aortic thrombosis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1429, 2012-01 ,pp. : 14-15

Adis International

Access to resources Recommend Favorite

Cytarabine/daunorubicin: Neutropenia and hidradenitis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1395, 2012-01 ,pp. : 17-18

Adis International

Access to resources Recommend Favorite

Antineoplastics: Melanomas in situ (first report with mercaptopurine, vincristine and daunorubicin) and dysplastic naevi (first report with asparaginase, daunorubicin and vincristine): case report

By  

Reactions Weekly, Vol. 1, Iss. 1154, 2007-01 ,pp. : 6-7

Adis International

Access to resources Recommend Favorite